Skip to content

Engaging with digital tool to help detect early signs of anxiety, depression and borderline personality disorder in adolescents and young adults

Multimodal pre-screening interviews with adolescents and young adults for developing an explainable artificial intelligence model and privacy-preserving synthetic data to assess risk of anxiety, depression and borderline personality disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN55639530
Enrollment
240
Registered
2026-03-09
Start date
2026-01-12
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early identification of anxiety, depression and borderline personality disorder in adolescents and young adults receiving outpatient and community mental health care Mental and Behavioural Disorders

Interventions

Adolescents and young adults aged 12–20 years, with anxiety, depression, borderline personality disorder or no mental disorder (controls), will be recruited from child and adolescent mental health ser

Sponsors

University Medical Centre Maribor, Unit for pediatric and adolescent psychiatry
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 20 Years

Inclusion criteria

Inclusion criteria: Clinical group: 1. Adolescents and young adults aged 12–20 years at the time of consent/assent. 2. Currently in outpatient or inpatient care at University Medical Centre Maribor or in a collaborating child and adolescent psychiatry service. 2. Presence of symptoms consistent with at least one target condition: anxiety disorder, depressive disorder or borderline personality disorder, as determined by the treating clinician and/or clinical records. 3. Sufficient cognitive abilities to understand questions and provide meaningful answers. 4. Fluent in Slovenian. 5. Able and willing to complete the full study visit (interview, recordings and questionnaires). 6. Provision of informed consent by the participant (from age 15) and/or parent/legal guardian with assent from younger participants. Control group: 1. Adolescents and young adults aged 12–20 years at the time of consent/assent. 2. Recruited from schools, universities, community settings or paediatric services where they are being seen for non-psychiatric reasons. 3. No history of formally diagnosed mental disorder and no clinically significant indication of mental disorder on screening questionnaires (borderline scores assessed case-by-case by the research psychiatrist). 4. Sufficient cognitive abilities to understand questions and provide meaningful answers. 5. Fluent in Slovenian. 6. Able and willing to complete the full study visit (interview, recordings and questionnaires). 7. Provision of informed consent by the participant (from age 15) and/or parent/legal guardian with assent from younger participants.

Exclusion criteria

Exclusion criteria: Clinical group: 1. Intellectual disability or developmental/behavioural disorder that prevents understanding or meaningful participation in the interview. 2. Acute, life-threatening psychiatric condition or need for emergency intervention (for example severe agitation, aggression, acute psychosis). 3. Severe sensory or motor impairment (for example profound visual, hearing or speech impairment) that prevents effective interaction with the tablet-based system and cannot be reasonably accommodated. 4. Severe unstable physical illness or acute/chronic pain that would interfere with participation or reliability of responses. 5. Acute intoxication with or withdrawal from psychoactive substances at the time of assessment. Control group 1. Any formally diagnosed mental disorder. 2. Clinically significant suspicion of mental disorder based on validated self-report screening instruments, confirmed by the study psychiatrist. 3. Intellectual disability or developmental/behavioural disorder that prevents understanding or meaningful participation. 4. Acute psychiatric crisis or high current suicide risk requiring urgent care. 5. Severe sensory or motor impairment, severe unstable physical illness or acute intoxication/withdrawal, as above.

Countries

Slovenia

Contacts

Public ContactIzidor Mlakar
izidor.mlakar@um.si+386 2 220 7267

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026